Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome ; day:27 ; month:5 ; year:2019 ; pages:1-12
Clinical pharmacokinetics ; (27.5.2019), 1-12
- Urheber
-
Admiraal, Rick
Jol-van der Zijde, Cornelia M.
Furtado Silva, Juliana M.
Knibbe, Catherijne A. J.
Lankester, Arjan C.
Boelens, Jaap Jan
Hale, Goeff
Etuk, Aniekan
Wilson, Melanie
Adams, Stuart
Veys, Paul
van Kesteren, Charlotte
Bredius, Robbert G. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-019-00782-0
- URN
-
urn:nbn:de:101:1-2019112021545069773856
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Admiraal, Rick
- Jol-van der Zijde, Cornelia M.
- Furtado Silva, Juliana M.
- Knibbe, Catherijne A. J.
- Lankester, Arjan C.
- Boelens, Jaap Jan
- Hale, Goeff
- Etuk, Aniekan
- Wilson, Melanie
- Adams, Stuart
- Veys, Paul
- van Kesteren, Charlotte
- Bredius, Robbert G. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation
Development of a dosing system for individualized therapy with oral films
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
PK-DB: pharmacokinetics database for individualized and stratified computational modeling
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation
Development of a dosing system for individualized therapy with oral films
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
PK-DB: pharmacokinetics database for individualized and stratified computational modeling
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation
Development of a dosing system for individualized therapy with oral films
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
PK-DB: pharmacokinetics database for individualized and stratified computational modeling
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
OptiDose : Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control